Legal & General Global Health and Pharmaceuticals Index Trust

Select share classes

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation

Category Sector Equity Healthcare


star-filledstar-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

133.60p

arrow-up0.80p (+0.60%)

Fund Code

LGGPA

B0CNH38

GB00B0CNH387

Prices updated as at 12 Dec 2025
|
Prices in GBX

Investment objective
The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied. Therefore, the Fund’s performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors. The Benchmark Index is comprised of shares in companies engaged in health, pharmaceuticals and biotechnology. The Fund is a Replicating Fund as it seeks to replicate as closely as possible the constituents of the Benchmark Index by holding all, or substantially all, of the assets comprising the Benchmark Index in similar proportions to their weightings in the Benchmark Index. The Fund will have at least 90% exposure to assets that are included in the Benchmark Index.

Portfolio as of 31/10/2025

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Stock style

Large value

39.92%

% Weight
Value
Core
Growth
Large

40

25

17

Medium

6

7

5

Small

0

0

0

Valuation

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare

16.77

16.77
18.97

2.08

2.08
1.92

3.82

3.82
4.17

12.68

12.68
13.61

Growth rate

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare

7.91%

7.91%
9.32%

2.07%

2.07%
1.51%

3.16%

3.16%
4.08%

Top 10 holdings

1
Eli Lilly and Co
Sector
-
Country
United States
% of assets
9.26312
2
Johnson & Johnson
Sector
-
Country
United States
% of assets
6.18348
3
AbbVie Inc
Sector
-
Country
United States
% of assets
5.28899
4
UnitedHealth Group Inc
Sector
-
Country
United States
% of assets
4.27819
5
Roche Holding AG
Sector
-
Country
Switzerland
% of assets
3.17095
6
Novartis AG Registered Shares
Sector
-
Country
Switzerland
% of assets
3.13546
7
AstraZeneca PLC
Sector
-
Country
United Kingdom
% of assets
2.95188
8
Abbott Laboratories
Sector
-
Country
United States
% of assets
2.93173
9
Merck & Co Inc
Sector
-
Country
United States
% of assets
2.91731
10
Thermo Fisher Scientific Inc
Sector
-
Country
United States
% of assets
2.90734
Assets in top 10 holdings %

43.03%

Total no. of equity holdings

165.00

Total no. of bond holdings

-

Stock sectors

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
Sector Equity Healthcare

0.34%

Basic materials

0.32%
-

Con cyclical

-
-

Financial svs

0.03%
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

99.66%

Con defensive

0.04%
-

Healthcare

99.61%
-

Utilities

-
-


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.